Evidence map›Paper›PMID 29133417›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Human resistin protects against endotoxic shock by blocking LPS-TLR4 interaction.

Jessica C Jang, Jiang Li, Luca Gambini, Hashini M Batugedara, Sandeep Sati, Mitchell A Lazar, Li Fan, Maurizio Pellecchia, Meera G Nair

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 2 syntheses or guidelines pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Defining mesenchymal stem/stromal cell-induced myeloid-derived suppressor cells using single-cell transcriptomics.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jessica C JangDivision of Biomedical Sciences, University of California, Riverside, CA 92521.
Jiang LiDivision of Biomedical Sciences, University of California, Riverside, CA 92521.ORCID 0000-0003-0511-8131
Luca GambiniDivision of Biomedical Sciences, University of California, Riverside, CA 92521.
Hashini M BatugedaraDivision of Biomedical Sciences, University of California, Riverside, CA 92521.
Sandeep SatiBiochemistry Department, University of California, Riverside, CA 92521.
Mitchell A LazarInstitute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
Li FanBiochemistry Department, University of California, Riverside, CA 92521.
Maurizio PellecchiaDivision of Biomedical Sciences, University of California, Riverside, CA 92521.
Meera G NairDivision of Biomedical Sciences, University of California, Riverside, CA 92521; meera.nair@ucr.edu.ORCID 0000-0002-1807-5161
University of California, Riverside · USUniversity of Pennsylvania · US

Funding

ZINC FINGER PROTEINS IN EARLY KIDNEY DEVELOPMENTP01DK049210 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI AHIMA, REXFORD S. · 1995 to 2016
$26.9M
RELM-alpha regulation of hookworm-induced lung inflammationR01AI091759 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI NAIR, MEERA GOH · 2011 to 2015
$2.0M
Acquisition of a Scalable Storage Cluster for Data Intensive NIH ResearchS10OD016290 · OD · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI GIRKE, THOMAS · 2014 to 2014
$593k
Human resistin regulation of inflammation and endotoxic shockR21AI137830 · NIAID · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI NAIR, MEERA GOH · 2018 to 2019
$427k
NIAID NIH HHS R01 AI091759NIAID NIH HHS R21 AI137830NIDDK NIH HHS P01 DK049210NIH HHS S10 OD016290
6 · The paper itself

Abstract

Helminths trigger multiple immunomodulatory pathways that can protect from sepsis. Human resistin (hRetn) is an immune cell-derived protein that is highly elevated in helminth infection and sepsis. However, the function of hRetn in sepsis, or whether hRetn influences helminth protection against sepsis, is unknown. Employing hRetn-expressing transgenic mice (h

Indexed as

AnimalsBiological TherapyDisease Models, AnimalFemaleGram-Negative BacteriaHumansLipopolysaccharide ReceptorsLipopolysaccharidesMaleMiceMice, Inbred C57BLMice, TransgenicNippostrongylusProtective AgentsProtein Serine-Threonine KinasesRecombinant ProteinsLipopolysaccharide ReceptorsLipopolysaccharidesProtective AgentsProtein Serine-Threonine KinasesRecombinant ProteinsResistinRETN protein, humanSTAT3 protein, humanStat3 protein, mouseSTAT3 Transcription FactorTBK1 protein, humanTbk1 protein, mouseTLR4 protein, humanTlr4 protein, mouseToll-Like Receptor 4inflammationLPSresistinsepsisTLR4

Identifiers

PMID29133417
PMCPMC5715788
OpenAlexW2769633717

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.